nach oben

Clinical Oral Investigations

Erschienen in:

08.03.2017 | Original Article

Gene expression of miRNA-138 and cyclin D1 in oral lichen planus

verfasst von: Noha A. Ghallab, Rehab Fawzy Kasem, Safa Fathy Abd El-Ghani, Olfat G. Shaker

Erschienen in: Clinical Oral Investigations | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aimed to evaluate microRNA-138 (miR-138) gene expression and its target cyclin D1 (CCND1) gene and protein expression in oral lichen planus (OLP) mucosa in an attempt to investigate their possible roles in OLP immunopathogenesis.

Methods

Sixty oral biopsy specimens were harvested from 30 healthy subjects and 30 OLP patients, subdivided into reticular, atrophic, and erosive groups (n = 10 each). Samples were subjected to quantitative real-time polymerase chain reaction analysis for quantification of miR-138 and CCND1 relative gene expression and immunohistochemical analysis to determine CCND1 protein expression.

Results

Samples from OLP patients had a significant underexpression of miR-138 gene and overexpression of CCND1 at both gene and protein levels compared to normal mucosa samples. The lowest levels of miR-138 expression were observed in atrophic and erosive OLP compared to reticular OLP, and the highest levels of CCND1 gene and protein expression were in atrophic OLP. An inverse correlation was demonstrated between the miR-138 expression and both CCND1 gene and protein expression in OLP patients. A significant positive correlation between CCND1 gene and protein expression was also observed.

Conclusion

Downregulation of miR-138 increases the gene and protein expression of its potential target CCND1 in OLP mucosa which might have a pivotal role in the disease pathogenesis.

Clinical relevance

This research implied that miR-138 may have a role in identification of symptomatic OLP lesions. MiR-138 might be considered as a potential tool in future OLP molecular therapy.

Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus—a review. J Oral Pathol Med. 39(10):729–734. doi:10.1111/j.1600-0714.2010.00946.x CrossRefPubMed

Kurago ZB (2016) Etiology and pathogenesis of oral lichen planus: an overview. Oral Surg Oral Med Oral Pathol Oral Radiol 122(1):72–80. doi:10.1016/j.oooo.2016.03.011 CrossRefPubMed

Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A et al (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365CrossRefPubMed

Lavanya N, Jayanthi P, Rao UK, Ranganathan K (2011) Oral lichen planus: an update on pathogenesis and treatment. J Oral Maxillofac Pathol 15(2):127–132. doi:10.4103/0973-029x.84474 CrossRefPubMedPubMedCentral

Silverman S Jr (2000) Oral lichen planus: a potentially premalignant lesion. J Oral Maxillofac Surg 58(11):1286–1288. doi:10.1053/joms.2000.16630 CrossRefPubMed

Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 100(2):164–178. doi:10.1016/j.tripleo.2004.06.076 CrossRefPubMed

van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45(4–5):317–323. doi:10.1016/j.oraloncology.2008.05.016 CrossRefPubMed

Zuo YL, Gong DP, Li BZ, Zhao J, Zhou LY, Shao FY et al (2015) The TF-miRNA coregulation network in oral lichen planus. Biomed Res Int 2015:731264. doi:10.1155/2015/731264 CrossRefPubMedPubMedCentral

Gassling V, Hampe J, Acil Y, Braesen JH, Wiltfang J, Hasler R (2013) Disease-associated miRNA-mRNA networks in oral lichen planus. PLoS One 8(5):e63015. doi:10.1371/journal.pone.0063015 CrossRefPubMedPubMedCentral

10.

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297CrossRefPubMed

11.

Erson AE, Petty EM (2008) MicroRNAs in development and disease. Clin Genet 74(4):296–306. doi:10.1111/j.1399-0004.2008.01076.x CrossRefPubMed

12.

Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37(7):766–770. doi:10.1038/ng1590 CrossRefPubMed

13.

Chen K, Rajewsky N (2007) The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8(2):93–103. doi:10.1038/nrg1990 CrossRefPubMed

14.

Anglicheau D, Muthukumar T, Suthanthiran M (2010) MicroRNAs: small RNAs with big effects. Transplantation 90(2):105–112. doi:10.1097/TP.0b013e3181e913c2 CrossRefPubMedPubMedCentral

15.

Dai R, Ahmed SA (2011) MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 157(4):163–179. doi:10.1016/j.trsl.2011.01.007 CrossRefPubMedPubMedCentral

16.

Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S et al (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 12(12):1160–1165. doi:10.1016/j.autrev.2013.07.003 CrossRefPubMed

17.

Chang SS, Jiang WW, Smith I, Poeta LM, Begum S, Glazer C et al (2008) MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 123(12):2791–2797. doi:10.1002/ijc.23831 CrossRefPubMedPubMedCentral

18.

Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I, Wang C et al (2012) Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 48(8):686–691. doi:10.1016/j.oraloncology.2012.02.020 CrossRefPubMedPubMedCentral

19.

Wang H, Zhang G, Wu Z, Lu B, Yuan D, Li X et al (2015) MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas. J Cancer Res Ther 11(Suppl 2):C216–C221. doi:10.4103/0973-1482.168189 PubMed

20.

Li J, Lei H, Xu Y, Tao ZZ (2015) miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo. PLoS One 10(8):e0135265. doi:10.1371/journal.pone.0135265 CrossRefPubMedPubMedCentral

21.

Yu X, Li Z (2016) MicroRNA expression and its implications for diagnosis and therapy of tongue squamous cell carcinoma. J Cell Mol Med 20(1):10–16. doi:10.1111/jcmm.12650 CrossRefPubMed

22.

Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN et al (2009) Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 18(24):4818–4829. doi:10.1093/hmg/ddp446 CrossRefPubMed

23.

Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ et al (2010) Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog 49(2):183–189. doi:10.1002/mc.20588 PubMedPubMedCentral

24.

Yang Y, Li YX, Yang X, Jiang L, Zhou ZJ, Zhu YQ (2013) Progress risk assessment of oral premalignant lesions with saliva miRNA analysis. BMC Cancer 13:129. doi:10.1186/1471-2407-13-129 CrossRefPubMedPubMedCentral

25.

Bueno MJ, Malumbres M (2011) MicroRNAs and the cell cycle. Biochim Biophys Acta 1812(5):592–601. doi:10.1016/j.bbadis.2011.02.002 CrossRefPubMed

26.

Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE et al (2010) Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma. Int J Cancer 127(3):505–512. doi:10.1002/ijc.25320 CrossRefPubMedPubMedCentral

27.

Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT (2012) MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 33(5):1113–1120. doi:10.1093/carcin/bgs113 CrossRefPubMedPubMedCentral

28.

Jiang L, Dai Y, Liu X, Wang C, Wang A, Chen Z et al (2011) Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Hum Genet 129(2):189–197. doi:10.1007/s00439-010-0915-3 CrossRefPubMed

29.

Liu X, Jiang L, Wang A, Yu J, Shi F, Zhou X (2009) MicroRNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett 286(2):217–222. doi:10.1016/j.canlet.2009.05.030 CrossRefPubMedPubMedCentral

30.

Jin Y, Wang C, Liu X, Mu W, Chen Z, Yu D et al (2011) Molecular characterization of the microRNA-138-Fos-like antigen 1 (FOSL1) regulatory module in squamous cell carcinoma. J Biol Chem 286(46):40104–40109. doi:10.1074/jbc.C111.296707 CrossRefPubMedPubMedCentral

31.

Liu X, Wang C, Chen Z, Jin Y, Wang Y, Kolokythas A et al (2011) MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem J 440(1):23–31. doi:10.1042/bj20111006 CrossRefPubMedPubMedCentral

32.

Jin Y, Chen D, Cabay RJ, Wang A, Crowe DL, Zhou X (2013) Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma. Int Rev Cell Mol Biol 303:357–385. doi:10.1016/b978-0-12-407697-6.00009-x CrossRefPubMedPubMedCentral

33.

Liu X, Lv XB, Wang XP, Sang Y, Xu S, Hu K et al (2012) MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene. Cell Cycle 11(13):2495–2506. doi:10.4161/cc.20898 CrossRefPubMed

34.

Grillo M, Bott MJ, Khandke N, McGinnis JP, Miranda M, Meyyappan M et al (2006) Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression. Breast Cancer Res Treat 95(2):185–194. doi:10.1007/s10549-005-9066-y CrossRefPubMed

35.

Koontongkaew S, Chareonkitkajorn L, Chanvitan A, Leelakriangsak M, Amornphimoltham P (2000) Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncol 36(4):334–339CrossRefPubMed

36.

Yao X, Yin C, Shen LJ, Xie SM (2007) Expressions of NF--kappaBp65, TRAF2, cyclinD1 and their association with cell apoptosis in oral lichen planus. Nan Fang Yi Ke Da Xue Xue Bao 27(11):1657–1660PubMed

37.

Zhang Z, Chen L, Hong Q, Sun S (2010) Expression of TGF-β1, Smad 4 and cyclin D1 in oral lichen planus. Chinese J Conser Dent 11

38.

Abid AM, Merza MS (2014) Immunohistochemical expression of cyclin D1 and NF-KB p65 in oral lichen planus and oral squamous cell carcinoma (comparative study). J Bagh College Dentistry 26(1):80–87CrossRef

39.

van Oijen MG, Tilanus MG, Medema RH, Slootweg PJ (1998) Expression of p21 (Waf1/Cip1) in head and neck cancer in relation to proliferation, differentiation, p53 status and cyclin D1 expression. J Oral Pathol Med. 27(8):367–375CrossRefPubMed

40.

Chen Q, Luo G, Li B, Samaranayake LP (1999) Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. J Oral Pathol Med. 28(4):158–164CrossRefPubMed

41.

Poomsawat S, Buajeeb W, Khovidhunkit SO, Punyasingh J (2010) Alteration in the expression of cdk4 and cdk6 proteins in oral cancer and premalignant lesions. J Oral Pathol Med. 39(10):793–799. doi:10.1111/j.1600-0714.2010.00909.x CrossRefPubMed

42.

Bushati N, Cohen SM (2007) microRNA functions. Annu Rev Cell Dev Biol 23:175–205. doi:10.1146/annurev.cellbio.23.090506.123406 CrossRefPubMed

43.

van der Meij EH, Mast H, van der Waal I (2007) The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol 43(8):742–748. doi:10.1016/j.oraloncology.2006.09.006 CrossRefPubMed

44.

Fitzpatrick SG, Hirsch SA, Gordon SC (2014) The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 145(1):45–56. doi:10.14219/jada.2013.10 CrossRefPubMed

45.

Abramson JH (1966) The Cornell Medical Index as an epidemiological tool. Am J Public Health Nations Health 56(2):287–298CrossRefPubMedPubMedCentral

46.

Rad M, Hashemipoor MA, Mojtahedi A, Zarei MR, Chamani G, Kakoei S et al (2009) Correlation between clinical and histopathologic diagnoses of oral lichen planus based on modified WHO diagnostic criteria. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107(6):796–800. doi:10.1016/j.tripleo.2009.02.020 CrossRefPubMed

47.

Hirota M, Ito T, Okudela K, Kawabe R, Yazawa T, Hayashi H et al (2002) Cell proliferation activity and the expression of cell cycle regulatory proteins in oral lichen planus. J Oral Pathol Med. 31(4):204–212CrossRefPubMed

48.

Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101–1108CrossRefPubMed

49.

Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39(2):175–191CrossRefPubMed

50.

Arao TC, Guimaraes AL, de Paula AM, Gomes CC, Gomez RS (2012) Increased miRNA-146a and miRNA-155 expressions in oral lichen planus. Arch Dermatol Res 304(5):371–375. doi:10.1007/s00403-011-1197-x CrossRefPubMed

51.

da Silva Fonseca LM, do Carmo MA (2001) Identification of the AgNORs, PCNA and ck16 proteins in oral lichen planus lesions. Oral Dis 7(6):344–348CrossRefPubMed

52.

Rezaee M, Tadbir AA, Akbari B (2013) CDK6 expression in oral lichen planus. Middle-East J Sci Res 16(10):1297–1302. doi:10.5829/idosi.mejsr.2013.16.10.7647

53.

Gonzalez-Moles MA, Bascones-Ilundain C, Gil Montoya JA, Ruiz-Avila I, Delgado-Rodriguez M, Bascones-Martinez A (2006) Cell cycle regulating mechanisms in oral lichen planus: molecular bases in epithelium predisposed to malignant transformation. Arch Oral Biol 51(12):1093–1103. doi:10.1016/j.archoralbio.2006.06.007 CrossRefPubMed

54.

Zhang WY, Liu W, Zhou YM, Shen XM, Wang YF, Tang GY (2012) Altered microRNA expression profile with miR-27b down-regulation correlated with disease activity of oral lichen planus. Oral Dis 18(3):265–270. doi:10.1111/j.1601-0825.2011.01869.x CrossRefPubMed

55.

Danielsson K, Ebrahimi M, Wahlin YB, Nylander K, Boldrup L (2012a) Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol 26(11):1415–1419. doi:10.1111/j.1468-3083.2011.04306.x CrossRefPubMed

56.

Danielsson K, Wahlin YB, Gu X, Boldrup L, Nylander K (2012b) Altered expression of miR-21, miR-125b, and miR-203 indicates a role for these microRNAs in oral lichen planus. J Oral Pathol Med. 41(1):90–95. doi:10.1111/j.1600-0714.2011.01084.x CrossRefPubMed

57.

Hu JY, Zhang J, Cui JL, Liang XY, Lu R, Du GF et al (2013) Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine 62(1):141–145. doi:10.1016/j.cyto.2013.01.020 CrossRefPubMed

58.

Shen Z, Du G, Zhou Z, Liu W, Shi L, Xu H (2015) Aberrant expression of interleukin-22 and its targeting microRNAs in oral lichen planus: a preliminary study. J Oral Pathol Med. doi:10.1111/jop.12404

59.

Fu D, Yu W, Li M, Wang H, Liu D, Song X et al (2015) MicroRNA-138 regulates the balance of Th1/Th2 via targeting RUNX3 in psoriasis. Immunol Lett 166(1):55–62. doi:10.1016/j.imlet.2015.05.014 CrossRefPubMed

60.

Zhou X, Luan X, Chen Z, Francis M, Gopinathan G, Li W et al (2016) MicroRNA-138 inhibits periodontal progenitor differentiation under inflammatory conditions. J Dent Res 95(2):230–237. doi:10.1177/0022034515613043 CrossRefPubMedPubMedCentral

61.

Karatsaidis A, Schreurs O, Helgeland K, Axell T, Schenck K (2003) Erythematous and reticular forms of oral lichen planus and oral lichenoid reactions differ in pathological features related to disease activity. J Oral Pathol Med 32(5):275–281CrossRefPubMed

62.

Yang JG, Sun YR, Chen GY, Liang XY, Zhang J, Zhou G (2016) Different expression of MicroRNA-146a in peripheral blood CD4(+) T cells and lesions of oral lichen planus. Inflammation 39(2):860–866. doi:10.1007/s10753-016-0316-4 CrossRefPubMed

63.

Carlos de Vicente J, Herrero-Zapatero A, Fresno MF, Lopez-Arranz JS (2002) Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 38(3):301–308CrossRefPubMed

64.

Martin-Ezquerra G, Salgado R, Toll A, Gilaberte M, Baro T, Alameda Quitllet F et al (2010) Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC, TP53, CCDN1, EGFR and ERBB2 status in primary and metastatic tumours. Br J Dermatol 163(5):1028–1035. doi:10.1111/j.1365-2133.2010.09947.x CrossRefPubMed

65.

Bascones C, Gonzalez-Moles MA, Esparza G, Bravo M, Acevedo A, Gil-Montoya JA et al (2005) Apoptosis and cell cycle arrest in oral lichen planus hypothesis on their possible influence on its malignant transformation. Arch Oral Biol 50(10):873–881. doi:10.1016/j.archoralbio.2005.02.005 CrossRefPubMed

66.

Han LP, Fu T, Lin Y, Miao JL, Jiang QF (2016) MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interaction with cyclin D3. Tumour Biol 37(1):291–298. doi:10.1007/s13277-015-3757-8 CrossRefPubMed

Titel: Gene expression of miRNA-138 and cyclin D1 in oral lichen planus
verfasst von: Noha A. Ghallab
Rehab Fawzy Kasem
Safa Fathy Abd El-Ghani
Olfat G. Shaker
Publikationsdatum: 08.03.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 8/2017
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-017-2091-5

Neu im Fachgebiet Zahnmedizin

19.04.2024 | Vorhofflimmern | Nachrichten

Newsletter bestellen

Springer Medizin

Gene expression of miRNA-138 and cyclin D1 in oral lichen planus

Abstract

Objectives

Methods

Results

Conclusion

Clinical relevance

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter

Springer Medizin

Abstract

Objectives

Methods

Results

Conclusion

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Influence of enamel/dentin thickness on the toxic and esthetic effects of experimental in-office bleaching protocols

The effect of veneering on the marginal fit of CAD/CAM-generated, copy-milled, and cast metal copings

Liquid-based versus conventional cytology of oral brush biopsies: a split-sample pilot study

Early bone formation around immediately loaded implants with nanostructured calcium-incorporated and machined surface: a randomized, controlled histologic and histomorphometric study in the human posterior maxilla

Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?

Inhibitory effect of saliva on osteoclastogenesis in vitro requires toll-like receptor 4 signaling

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter